Henlius Brings In Abbott As Another Partner In Brazil
Local Player Eurofarma Had Recently Struck A $50.5m Deal
Chinese player Shanghai Henlius Biotech has out licensed semi-exclusive rights to some of its biosimilars in Brazil again, shortly after signing a major deal covering 16 Latin American countries.
